{"@id":"https://bioecon.ru/technology/in-vivo-high-throughput-antibody-discovery/","@type":"Technology","cluster":"therapeutics-platforms","formats":{"html":"https://cn.bioecon.ru/technology/in-vivo-high-throughput-antibody-discovery/","json":"https://cn.bioecon.ru/api/v1/technology/in-vivo-high-throughput-antibody-discovery/index.json"},"id":"in-vivo-high-throughput-antibody-discovery","industries":["pharma","biomanufacturing"],"lang":"cn","links":{"industries":["https://bioecon.ru/industries/pharma/","https://bioecon.ru/industries/biomanufacturing/"],"suppliers":["https://bioecon.ru/companies/novartis/","https://bioecon.ru/companies/lonza-group/","https://bioecon.ru/companies/genmab/","https://bioecon.ru/companies/tsingke-biotechnology/","https://bioecon.ru/companies/becton-dickinson/","https://bioecon.ru/companies/allozymes/","https://bioecon.ru/companies/vland-biotech/","https://bioecon.ru/companies/jiangsu-hengrui-medicine/","https://bioecon.ru/companies/caladan-bio/","https://bioecon.ru/companies/daiichi-sankyo/"]},"maturity":7,"name":"体内高通量抗体发现与定向进化平台","regions":["ch","eu","us","cn"],"risk":"medium","section":"technology","sector":"health-biomedicine","sources":[{"date":"2026-11-22","entity":"Swiss Biotech Directory 2026","kind":"vendor","urls":["https://www.swissbiotech.org/directory/"]}],"stages":[{"n":1,"title":"构象完整跨膜靶标免疫"},{"n":2,"title":"皮升级单液滴分泌组测定"},{"n":3,"title":"千赫兹高速光学液滴分选"},{"n":4,"title":"全自动机器人极速测序合成"}],"summary":"通过将转基因动物体内抗原免疫与微流控单细胞液滴超高通量筛选深度结合，直接从数百万个原代浆细胞中数小时内锁定针对多次跨膜蛋白的超高亲和力抗体。","url":"/technology/in-vivo-high-throughput-antibody-discovery/","verified":"2026-11-22"}